Perspectives on investigational drugs and immunotherapies for glioblastoma

Julie J. MillerStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information

William T. CurryStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information

Dan P. CahillStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information

Jörg DietrichStephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA;Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Declaration of interest

J Dietrich also received generous philanthropic support from the family foundations of Sheila McPhee, Ronald Tawil and Bryan Lockwood. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

J Dietrich has received funding and research support from the American Academy of Neurology Foundation [1200-219466], the American Cancer Society [1200-222362] and the National Institute of Health [RO1CA190901].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Perspectives on investigational drugs and immunotherapies for glioblastoma

Information for

Open access

Opportunities

Help and information

Perspectives on investigational drugs and immunotherapies for glioblastoma

Declaration of interest

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature